Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization

References

• Albertini R, Clewell H, Himmelstein MW, Morinello E, Olin S, Preston J, Scarano L, Smith M T, Swenberg J, Tice R, Travis C (2003). The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene. Regul Toxicol Pharmacol 37:105–132
   PubMed Web of Science ®Google Scholar
• Albertini RJ, Sweeney LM (2007). Propylene Oxide: Genotoxicity profile of a rodent nasal carcinogen. Crit Rev Toxicol 37:489–520
   PubMed Web of Science ®Google Scholar
• ATSDR (2006). Toxicological profile for vinyl chloride. Agency for Toxic Substances and Disease Registry; 1–329.
   Google Scholar
• Barbin A, Froment O, Boivin S, Marion M J, Belpoggi F, Maltoni C, Montesano R (1997). p53 gene mutation pattern in rat liver tumors induced by vinyl chloride. Cancer Res 57:1695–1698
   PubMed Web of Science ®Google Scholar
• Bechtold WE, Strunk MR, Thornton-Manning JR, Henderson RF (1995). Analysis of butadiene, butadiene monoxide, and butadiene dioxide in blood by gas chromatography/gas chromatography/mass spectroscopy. Chem Res Toxicol 8:182–187
   PubMed Web of Science ®Google Scholar
• Beckman R A, Loeb L A (2005). Genetic instability in cancer: Theory and experiment. Semin Cancer Biol 15:423–435
   PubMed Web of Science ®Google Scholar
• Beland F A, Churchwell M I, Doerge D R, Parkin D R, Malejka-Giganti D, Hewer A, Phillips D H, Carmichael P L, Gamboa Da Costa G, Marques M M (2004). Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans. J Natl Cancer Inst 96:1099–1104
   PubMedGoogle Scholar
• Beland F A, Kadlubar F F (1985). Formation and persistence of arylamine DNA adducts in vivo. Environ Health Perspect 62:19–30
   PubMed Web of Science ®Google Scholar
• Beland F A, Kadlubar F F (1990). Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In: Cooper CS, Grover PL, eds. Handbook of Experimental Pharmacology. Berlin, Heidelberg: Springer-Verlag, 267–325.
   Google Scholar
• Beranek D T (1990). Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res 231:11–30
   PubMed Web of Science ®Google Scholar
• Bond J A, Medinsky M A (1995). Factors modifying the disposition of inhaled organic compounds. In: McClellan RA, Henderson RF, eds. Concepts in Inhalation Toxicology. Washington, DC: Taylor & Francis, 289–316.
   Google Scholar
• Boysen G, Pachkowski BF, Nakamura J, Swenberg JA (2009). The formation and biological significance of N7-guanine adducts. Mutat Res, in press.
   PubMed Web of Science ®Google Scholar
• Brown CD, Asgharian B, Turner MJ, Fennell TR (1998). Ethylene oxide dosimetry in the mouse. Toxicol Appl Pharmacol 148:215–221
   PubMed Web of Science ®Google Scholar
• Cadet J, Berger M, Douki T, Ravanat J L (1997). Oxidative damage to DNA: Formation measurement and biological significance. Rev Physiol Biochem Pharmacol 131:1–87
   PubMedGoogle Scholar
• Casciano D A (2000). Development and utilization of primary hepatocyte culture systems to evaluate metabolism, DNA binding, and DNA repair of xenobiotics. Drug Metab Rev 32:1–13
   PubMed Web of Science ®Google Scholar
• Cavalieri E, Rogan E (2006). Catechol quinones of estrogens in the initiation of breast prostate and other human cancers: Keynote lecture. Ann N Y Acad Sci 1089:286–301
   PubMed Web of Science ®Google Scholar
• Checkoway H, Rice C H (1992). Time-weighted averages peaks and other indices of exposure in occupational epidemiology. Am J Ind Med 21:25–33
   PubMed Web of Science ®Google Scholar
• Chen T, Mittelstaedt R A, Aidoo A, Hamilton L P, Beland F A, Casciano D A, Heflich R H (2001). Comparison of hprt and laci mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminofluorene-treated Big Blue rats. Environ Mol Mutagen 37:195–202
   PubMed Web of Science ®Google Scholar
• Cohen S M, Klaunig J, Meek M E, Hill R N, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow D G, Seed J, Dellarco V, Fenner-Crisp P, Patton D (2004). Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci 78: 181–186.
   PubMed Web of Science ®Google Scholar
• Cohen S M, Meek M E, Klaunig J E, Patton D E, Fenner-Crisp P A (2003). The human relevance of information on carcinogenic modes of action: Overview. Crit Rev Toxicol 33: 581–589
   PubMed Web of Science ®Google Scholar
• Dahl A R (1990). Dose concepts for inhaled vapors and gases. Toxicol Appl Pharmacol 103:185–197
   PubMed Web of Science ®Google Scholar
• De Bont R, Van Larebeke N (2004). Endogenous DNA damage in humans: A review of quantitative data. Mutagenesis 19:169–185
   PubMed Web of Science ®Google Scholar
• De Fraipont F, El Atifi M, Gicquel C, Bertagna X, Chambaz E M, Feige J J (2000). Expression of the angiogenesis markers vascular endothelial growth factor-α, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: Correlation with genotypic alterations. J Clin Endocrinol Metab 85:4734–4741
   PubMed Web of Science ®Google Scholar
• Delaney JC, Essigmann JM (2008). Biological properties of single chemical—DNA adducts: A twenty year perspective. Chem Res Toxicol 21:232–252
   PubMed Web of Science ®Google Scholar
• Donigan KA, Sweasy JB (2009). Sequence context-specific mutagenesis and base excision repair. Mol Carcinog 48:362–368
   PubMed Web of Science ®Google Scholar
• Dybdahl M, Risom L, Moller P, Autrup H, Wallin H, Vogel U, Bornholdt J, Daneshvar B, Dragsted LO, Weimann A, Poulsen HE, Loft S (2003). DNA adduct formation and oxidative stress in colon and liver of Big Blue rats after dietary exposure to diesel particles. Carcinogenesis 24:1759–66
   PubMed Web of Science ®Google Scholar
• ESCODD (2003). Measurement of DNA oxidation in human cells by chromatographic and enzymic methods. Free Radic Biol Med 34:1089–1099
   PubMed Web of Science ®Google Scholar
• Faraglia B, Chen SY, Gammon MD, Zhang Y, Teitelbaum SL, Neugut AI, Ahsan H, Garbowski GC, Hibshoosh H, Lin D, Kadlubar FF, Santella RM (2003). Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: The influence of tobacco smoke. Carcinogenesis 24:719–725
   PubMedGoogle Scholar
• Fearon E R, Vogelstein B (1990). A genetic model for colorectal tumorigenesis. Cell 61:759–767
   PubMed Web of Science ®Google Scholar
• Feinberg A P (2001). Cancer epigenetics takes center stage. Proc Natl Acad Sci U S A 98:392–394
   PubMed Web of Science ®Google Scholar
• Fleming T R, Demets D L (1996). Surrogate end points in clinical trials: Are we being misled? Ann Intern Med 125:605–613
   PubMed Web of Science ®Google Scholar
• Friedberg E C, Walker G C, Siede W, Wood R D, Schultz R A, Ellenberger T (2005). DNA Repair and Mutagenesis. New York: ASM Press.
   Google Scholar
• Fu P P, Von Tungeln L S, Yi P, Xia Q, Casciano D A, Flammang T J, Kadlubar F F (1998). Neonatal mouse tumorigenicity assay. Drug Inform J 32:711–728
   Web of Science ®Google Scholar
• Goth R, Rajewsky M F (1974). Persistence of O6-ethylguanine in rat-brain DNA: Correlation with nervous system-specific carcinogenesis by ethylnitrosourea. Proc Natl Acad Sci U S A 71:639–643
   PubMed Web of Science ®Google Scholar
• Groopman J D, Kensler T W (2005). Role of metabolism and viruses in aflatoxin- induced liver cancer. Toxicol Appl Pharmacol 206:131–137
   PubMed Web of Science ®Google Scholar
• Groopman JD, Wild CP, Hasler J, Junshi C, Wogan GN, Kensler T (1993). Molecular epidemiology of aflatoxin exposures: Validation of aflatoxin-N7-guanine levels as a biomarker in experimental rat models and humans. Environ Health Perspect 99:107–113
   PubMed Web of Science ®Google Scholar
• Guengerich F P (1990). Enzymatic oxidation of xenobiotic chemicals. Crit Rev Biochem Mol Biol 25:97–153
   PubMed Web of Science ®Google Scholar
• Guo H H, Choe J, Loeb L A (2004). Protein tolerance to random amino acid change. Proc Natl Acad Sci U S A 101:9205–9210
   PubMed Web of Science ®Google Scholar
• Gupta P B, Mani S, Yang J, Hartwell K, Weinberg R A (2005). The evolving portrait of cancer metastasis. Cold Spring Harb Symp Quant Biol 70:291–297
   PubMedGoogle Scholar
• Gupta R C, Lutz W K (1999). Background DNA damage for endogenous and unavoidable exogenous carcinogens: A basis for spontaneous cancer incidence? Mutat Res 424:1–8
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg R A (2000). The hallmarks of cancer. Cell 100:57–70
   PubMed Web of Science ®Google Scholar
• Hard G C, Iatropoulos M J, Jordan K, Radi L, Kaltenberg O P, Imondi A R, and Williams G M (1993). Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female crl:Cd(br) rats. Cancer Res 53:4534–4541
   PubMed Web of Science ®Google Scholar
• Hemminki K, Rajaniemi H, Lindahl B, Moberger B (1996). Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res 56:4374–4377
   PubMed Web of Science ®Google Scholar
• Himmelstein M W, Turner M J, Asgharian B, Bond J A (1994). Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis 15:1479–1486
   PubMed Web of Science ®Google Scholar
• Himmelstein MW, Boogaard PJ, Cadet J, Farmer PB, Kim JH, Martin EA, Persaud R, Shuker DEG (2009). Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage. Crit Rev Toxicol 39:this issue. IARC (1987). Treosulphan IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Suppl 7:363.
   Google Scholar
• Kanuri M, Finneman J, Harris C M, Harris T M, Lloyd R S (2001). Efficient nonmutagenic replication bypass of DNAs containing β-adducts of styrene oxide at adenine N6. Environ Mol Mutagen 38:357–360
   PubMed Web of Science ®Google Scholar
• Kasai H (1997). Analysis of a form of oxidative DNA damage 8-hydroxy-2’- deoxyguanosine as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387:147–163
   PubMed Web of Science ®Google Scholar
• Katayama S, Ohmori T, Maeura Y, Croci T, Williams GM (1984). Early stages of N2-fluorenylacetamide induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development. J Natl Cancer Inst 73:141–149
   PubMedGoogle Scholar
• Kleihues P, Bucheler J (1977). Long-term persistence of O6-methylguanine in rat brain DNA. Nature 269:625–626
   PubMed Web of Science ®Google Scholar
• Klimisch H J, Andreae M, Tillmann U (1997). A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol 25:1–5
   PubMed Web of Science ®Google Scholar
• Kocks C, Rajewsky K (1989). Stable expression and somatic hypermutation of antibody v regions in B-cell developmental pathways. Annu Rev Immunol 7:537–559.
   PubMed Web of Science ®Google Scholar
• Krutovskikh V A, Oyamada M, Yamasaki H (1991). Sequential changes of gap- junctional intercellular communications during multistage rat liver carcinogenesis: Direct measurement of communication in vivo. Carcinogenesis 12:1701–1706
   PubMed Web of Science ®Google Scholar
• Kunz C, Saito Y, Schär P (2009). DNA Repair in mammalian cells: Mismatched repair: variations on a theme. Cell Mol Life Sci 66:1021–1038
   PubMedGoogle Scholar
• La D K, Swenberg J A (1997). Carcinogenic alkylating agents. In: Sipes IG, McQueen CA, Gandolfi AJ, eds. Comprehensive Toxicology. Vol 12. Chemical Carcinogens and Anticarcinogens. Elsevier Oxford: Elsevier, 111–140.
   Google Scholar
• Latham GJ, Zhou L, Harris CM, Harris TM, Lloyd RS (1993). The replication fate of R- and S-styrene oxide adducts on adenine N6 is dependent on both the chirality of the lesion and the local sequence context. J Biol Chem 268:23427–23434
   PubMed Web of Science ®Google Scholar
• Lee M S, Faller T H, Kreuzer P E, Kessler W, Csanady G A, Putz C, Rios-Blanco M N, Pottenger L H, Segerback D, Osterman-Golkar S, Swenberg J A, Filser J G (2005). Propylene oxide in blood and soluble nonprotein thiols in nasal mucosa and other tissues of male Fischer F344/N rats exposed to propylene oxide vapors—relevance of glutathione depletion for propylene oxide-induced rat nasal tumors. Toxicol Sci 83:177–189
   PubMed Web of Science ®Google Scholar
• Lewis R, Rempala G, Dell L D, Mundt K A (2003). Vinyl chloride and liver and brain cancer at a polymer production plant in Louisville, Kentucky. J Occup Environ Med 45:533–537
   PubMed Web of Science ®Google Scholar
• Lewis R W, Billington R, Debryune E, Gamer A, Lang B, Carpanini F (2002). Recognition of adverse and nonadverse effects in toxicity studies. Toxicol Pathol 30:66–74
   PubMed Web of Science ®Google Scholar
• Loeb L A, Loeb K R, Anderson J P (2003). Multiple mutations and cancer. Proc Natl Acad Sci U S A 100:776–781
   PubMed Web of Science ®Google Scholar
• Marion M J, Boivin-Angele S (1999). Vinyl chloride-specific mutations in humans and animals. IARC Sci Publ 315–324
   PubMedGoogle Scholar
• McCarthy L S, Power M, Munkittrick K R (2002). Bioindicators versus biomakers in ecological risk assessment. Hum Ecol Risk Assess 8:159–164
   Web of Science ®Google Scholar
• McKinzie P B, Delongchamp R R, Chen T, Parsons B L (2006). ACB-PCR measurement of K-ras codon 12 mutant fractions in livers of Big Blue rats treated with N-hydroxy-2-acetylaminofluorene. Mutagenesis 21:391–397
   PubMed Web of Science ®Google Scholar
• Meek M E, Bucher J R, Cohen S M, Dellarco V, Hill R N, Lehman-McKeeman L D, Longfellow D G, Pastoor T, Seed J, Patton D E (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33:591–653
   PubMed Web of Science ®Google Scholar
• Meng Q, Walker D M, Scott B R, Seilkop S K, Aden J K, Walker V E (2004). Characterization of hprt mutations in cDNA and genomic DNA of T-cell mutants from control and 1,3-butadiene-exposed male B6C3F1 mice and F344 rats. Environ Mol Mutagen 43:75–92
   Google Scholar
• Miller E C, Miller J A (1979). Milestones in chemical carcinogenesis. Semin Oncol 6:445–460
   PubMed Web of Science ®Google Scholar
• Miller F J, Kimbell J S (1995). Regional dosimetry of inhaled reactive gases. In: McClellan RA, Henderson RF, eds. Concepts in Inhalation Toxicology. Washington, DC: Taylor & Francis, 257–288.
   Google Scholar
• Mitelman F, Mertens F, Johansson B (1997). A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15 (Spec. No.): 417–474
   PubMed Web of Science ®Google Scholar
• Mittelstaedt R A, Manjanatha M G, Shelton S D, Lyn-Cook L E, Chen J B, Aidoo A, Casciano D A, Heflich R H (1998). Comparison of the types of mutations induced by 7,12-dimethylbenz[a]anthracene in the lacI and hprt genes of Big Blue rats. Environ Mol Mutagen 31:149–156
   PubMed Web of Science ®Google Scholar
• Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A (1999). Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59:3317–3320
   PubMed Web of Science ®Google Scholar
• Monroe J J, Kort K L, Miller J E, Marino D R, Skopek T R (1998). A comparative study of in vivo mutation assays: Analysis of hprt lacI cii/ci and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice. Mutat Res 421:121–136
   PubMed Web of Science ®Google Scholar
• Morinello E J, Ham A J, Ranasinghe A, Nakamura J, Upton P B, Swenberg J A (2002). Molecular dosimetry and repair of N2,3-ethenoguanine in rats exposed to vinyl chloride. Cancer Res 62:5189–5195
   PubMed Web of Science ®Google Scholar
• Moriya M, Spiegel S, Fernandes A, Amin S, Liu T, Geacintov N, Grollman AP (1996). Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2’-deoxyguanosine DNA adducts: Marked effects of host cell sequence context and chirality. Biochemistry 35:16646–51
   PubMed Web of Science ®Google Scholar
• Mutlu E, Collins L B, Stout M B, Upton P B, Winsett D, Hatch G, Evansky P, Swenberg J A (2009). Development and application of an LC-MS/MS method for the detection of the vinyl chloride-induced DNA adduct N2,3-ethenoguanine in tissues of adult and weanling rats following exposure to [13C2]-VC. In preparation.
   Google Scholar
• Nair J, Barbin A, Velic I, Bartsch H (1999). Etheno DNA-base adducts from endogenous reactive species. Mutat Res 424:59–69
   PubMed Web of Science ®Google Scholar
• Nakamura J, Swenberg J A (1999). Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res 59:2522–2526
   PubMed Web of Science ®Google Scholar
• Nath R G, Randerath K, Li D, Chung F L (1996). Endogenous production of DNA adducts. Regul Toxicol Pharmacol 23:22–28
   PubMed Web of Science ®Google Scholar
• Nesnow S, Ross J A, Mass M J, Stoner G D (1998). Mechanistic relationships between DNA adducts oncogene mutations and lung tumorigenesis in strain A mice. Exp Lung Res 24:395–405
   PubMed Web of Science ®Google Scholar
• Nowell P C (1976). The clonal evolution of tumor cell populations. Science 194:23–28
   PubMed Web of Science ®Google Scholar
• NRC (1987). Drinking Water and Health: Pharmacokinetics in Risk Assessment. 8. Washington, DC: National Academy Press.
   Google Scholar
• NRC (1991). Human Exposure Assessment for Airborne Pollutants: Advances and Opportunities. Washington, DC: National Academy Press.
   Google Scholar
• Otteneder M, Lutz W K (1999). Correlation of DNA adduct levels with tumor incidence: Carcinogenic potency of DNA adducts. Mutat Res 424:237–247
   PubMed Web of Science ®Google Scholar
• Park J H, Gelhaus S, Vedantam S, Oliva A L, Batra A, Blair IA, Troxel AB, Field J, Penning TM (2008). The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance. Chem Res Toxicol 21:1039–49
   PubMed Web of Science ®Google Scholar
• Paules R (2003). Phenotypic anchoring: Linking cause and effect. Environ Health Perspect 111:A338–339
   PubMed Web of Science ®Google Scholar
• Pfeifer G P, Denissenko M F, Olivier M, Tretyakova N, Hecht S S, Hainaut P (2002). Tobacco smoke carcinogens DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435–7451
   PubMed Web of Science ®Google Scholar
• Pitot H C (1990). Altered hepatic foci: Their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol 30:465–500
   PubMed Web of Science ®Google Scholar
• Pitot H C (1996). Stage-specific gene expression during hepatocarcinogenesis in the rat. J Cancer Res Clin Oncol 122:257–265
   PubMed Web of Science ®Google Scholar
• Poste G, Tzeng J, Doll J, Greig R, Rieman D, Zeidman I (1982). Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. Proc Natl Acad Sci U S A 79:6574–6578
   PubMed Web of Science ®Google Scholar
• Pottenger L H, Penman M, Moore N P, Priston R A, Thomas M (2004). Biological significance of DNA adducts: Summary of discussion of expert panel. Regul Toxicol Pharmacol 39:403–408
   PubMedGoogle Scholar
• Preston R J, Williams G M (2005). DNA-reactive carcinogens: Mode of action and human cancer hazard. Crit Rev Toxicol 35:673–683
   PubMed Web of Science ®Google Scholar
• Puisieux A, Lim S, Groopman J, Ozturk M (1991). Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res 51:6185–6189
   PubMed Web of Science ®Google Scholar
• Recio L, Donner M, Abernethy D, Pluta L, Steen A M, Wong B A, James A, Preston R J (2004). In vivo mutagenicity and mutation spectrum in the bone marrow and testes of B6C3F1 lacI transgenic mice following inhalation exposure to ethylene oxide. Mutagenesis 19:215–222
   PubMed Web of Science ®Google Scholar
• Recio L, Steen A M, Pluta L J, Meyer K G, Saranko C J (2001). Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem Biol Interact 135–136:325–341
   Web of Science ®Google Scholar
• Rubin Z, Rousseaux C G (1991). The limitations of toxicological pathology. In: Haschek WM, Rousseaux CG, eds. Handbook of Toxicologic Pathology. New York, NY: Academic Press, 131–142.
   Google Scholar
• Rundle A (2006). Carcinogen-DNA adducts as a biomarker for cancer risk. Mutat Res 600:23–36
   PubMed Web of Science ®Google Scholar
• Rusyn I, Asakura S, Li Y, Kosyk O, Koc H, Nakamura J, Upton P B, Swenberg J A (2005). Effects of ethylene oxide and ethylene inhalation on DNA adducts apurinic/apyrimidinic sites and expression of base excision DNA repair genes in rat brain, spleen and liver. DNA Repair (Amst) 4:1099–1110
   PubMed Web of Science ®Google Scholar
• Sander M, Cadet J, Casciano D A, Galloway S M, Marnett L J, Novak R F, Pettit S D, Preston R J, Skare J A, Williams G M, Van Houten B, Gollapudi B B (2005). Proceedings of a workshop on DNA adducts: Biological significance and applications to risk assessment. Toxicol Appl Pharmacol 208:1–20
   PubMed Web of Science ®Google Scholar
• Sansam C G, Roberts C W (2006). Epigenetics and cancer: Altered chromatin remodeling via snf5 loss leads to aberrant cell cycle regulation. Cell Cycle 5:621–624
   PubMed Web of Science ®Google Scholar
• Schlesinger R B (1995). Deposition and clearance of inhaled particles. In: McClellan RA, Henderson RF, eds. Concepts in Inhalation Toxicology. Washington, DC: Taylor & Francis, 191–224.
   Google Scholar
• Schulte P A (1989). A conceptual framework for the validation and use of biologic markers. Environ Res 48:129–144
   PubMed Web of Science ®Google Scholar
• Seed J, Carney E W, Corley R A, Crofton K M, Desesso J M, Foster P M, Kavlock R, Kimmel G, Klaunig J, Meek M E, Preston R J, Slikker W Jr, Tabacova S, Williams G M, Wiltse J, Zoeller R T, Fenner-Crisp P, Patton D E (2005). Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit Rev Toxicol 35:664–672
   PubMed Web of Science ®Google Scholar
• Seon B K, Takahashi N, Haba A, Matsuno F, Haruta Y, She X W, Harada N, Tsai H (2001). Angiogenesis and metastasis marker of human tumors. Rinsho Byori 49:1005–1013
   PubMedGoogle Scholar
• Shibutani S, Ravindernath A, Suzuki N, Terashima I, Sugarman S M, Grollman A P, Pearl M L (2000). Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen. Carcinogenesis 21:1461–1467
   PubMed Web of Science ®Google Scholar
• Sidransky H, Wagner BP, Morris HD (1961). Sex difference in liver tumorigenesis in rats ingesting N-2-fluorenylacetamide. J Natl Cancer Inst 26:151–187
   Google Scholar
• Slikker W Jr, Andersen M E, Bogdanffy M S, Bus J S, Cohen S D, Conolly R B, David R M, Doerrer N G, Dorman D C, Gaylor D W, Hattis D, Rogers J M, Setzer R W, Swenberg J A, Wallace K (2004a). Dose-dependent transitions in mechanisms of toxicity: Case studies. Toxicol Appl Pharmacol 201:226–294
   PubMed Web of Science ®Google Scholar
• Slikker W Jr, Andersen M E, Bogdanffy M S, Bus J S, Cohen S D, Conolly R B, David R M, Doerrer N G, Dorman D C, Gaylor D W, Hattis D, Rogers J M, Setzer RW, Swenberg J A, Wallace K (2004b). Dose-dependent transitions in mechanisms of toxicity. Toxicol Appl Pharmacol 201:203–225
   PubMed Web of Science ®Google Scholar
• Snipes M B (1995). Pulmonary retention of particles and fibers: Biokinetics and effects of exposure concentrations. In: McClellan RA, Henderson RF, eds. Concepts in Inhalation Toxicology. Washington, DC: Taylor & Francis, 225–256.
   Google Scholar
• Stevens D K, Bull R J, Nauman C H, Blancato J N (1991). Decision model for biomarkers of exposure. Regul Toxicol Pharmacol 14:286–296
   PubMed Web of Science ®Google Scholar
• Swenberg J A, Fedtke N, Fennel T R, Walker V E (1990). Relationships between carcinogen exposure, DNA adducts and carcinogenesis. In: Clayson DB, Munro IC, Shubick P, Swenberg JA, eds. Progress in Predictive Toxicology. Amsterdam, The Netherlands: Elsevier, 161–184.
   Google Scholar
• Swenberg J A, Fryar-Tita E, Jeong Y C, Boysen G, Starr T, Walker V E, Albertini R J (2008). Biomarkers in toxicology and risk assessment: Informing critical dose-response relationships. Chem Res Toxicol 21:253–265
   PubMed Web of Science ®Google Scholar
• Talaska G, Cudnik J, Jaeger M, Rothman N, Hayes R, Bhatnagar VJ, Kayshup SJ (1996). Development and application of non-invasive biomarkers for carcinogen-DNA adduct analysis in occupationally exposed populations. Toxicology 111:207–212
   PubMed Web of Science ®Google Scholar
• Tan N W, Li B F (1990). Interaction of oligonucleotides containing 6-O6- methylguanine with human DNA (cytosine-5-)-methyltransferase [published erratum appears in Biochemistry 1992 Aug 4;31(30):7008]. Biochemistry 29:9234–9240
   PubMed Web of Science ®Google Scholar
• Tang D, Phillips DH, Stampfer M, Mooney LA, Hsu Y, Cho S, Tsai WY, Ma J, Cole KJ, She MN, Perera FP (2001). Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res 61:6708–6712
   PubMed Web of Science ®Google Scholar
• Turk P W, Laayoun A, Smith S S, Weitzman S A (1995). DNA adduct 8- hydroxyl-2’-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 16:1253–1255
   PubMed Web of Science ®Google Scholar
• USEPA (1994). Methods for derivation of inhaled reference concentrations and application of inhalation dosimetry. Office of Research and Development US Environmental Protection Agency. Washington, DC. EPA/600/8-90/066F. Available online at http://wwwepagov/cgi-bin/claritgw?op-Display&document=clserv:ORD:0327;&rank=4&template=epa
   Google Scholar
• USEPA (2005a). Guidelines for carcinogen risk assessment. US Environmental Protection Agency. Washington, DC. EPA/630/P-03/001F 2005.
   Google Scholar
• USEPA (2005b). Supplemental guidance for assessing susceptibility from early life exposures to carcinogens. US Environmental Protection Agency. Washington, DC. EPA/630/R-03/003F 2005.
   Google Scholar
• Venkatesan R N, Treuting P M, Fuller E D, Goldsby R E, Norwood T H, Gooley T A, Ladiges W C, Preston B D, Loeb L A (2007). Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Mol Cell Biol 27:7669–7682
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler K W (2002). The Genetic Basis of Human Cancer. Columbus, OH: McGraw- Hill Professional.
   Google Scholar
• Vogelstein B, Kinzler K W (2004). Cancer genes and the pathways they control. Nat Med 10:789–799
   PubMed Web of Science ®Google Scholar
• Wagner J A, Williams S A, Webster C J (2007). Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs. Clin Pharmacol Ther 81:104–107
   PubMed Web of Science ®Google Scholar
• Walker V E, Wu K Y, Upton P B, Ranasinghe A, Scheller N, Cho M H, Vergnes J S, Skopek T R, Swenberg J A (2000). Biomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide. Carcinogenesis 21:1661–1669
   PubMed Web of Science ®Google Scholar
• Waters M D, Fostel J M (2004). Toxicogenomics and systems toxicology: Aims and prospects. Nat Rev Genet 5:936–948
   PubMed Web of Science ®Google Scholar
• Waters LS, Minesinger BK, Wiltrout ME, D’Souza S, Woodruff RV, Walker GC (2009). Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol Mol Biol Rev 73:134–154
   PubMed Web of Science ®Google Scholar
• White et al. (2008). Environ Health Perspect 117: 283–287.
   PubMed Web of Science ®Google Scholar
• Williams G M (1999). Chemically induced preneoplastic lesions in rodents as indicators of carcinogenic activity. IARC Sci Publ 146:185–202
   Google Scholar
• Williams G M, Iatropoulos M J, Enzmann H G (2007). Principles of testing for carcinogenic activity. In: Hayes AW, ed. Principles and Methods of Toxicology. Philadelphia, PA: Taylor & Francis, 1271–1322.
   Google Scholar
• Williams G M, Iatropoulos M J, Jeffrey A M (2000). Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine. Toxicol Pathol 28:388–395
   PubMed Web of Science ®Google Scholar
• Williams G M, Iatropoulos M J, Jeffrey A M (2004). Thresholds for the effects of 2-acetylaminofluorene in rat liver. Toxicol Pathol 32(Suppl 2): 85–91
   PubMedGoogle Scholar
• Williams G M, Jeffrey A M (2000). Oxidative DNA damage: Endogenous and chemically induced. Regul Toxicol Pharmacol 32:283–292
   PubMed Web of Science ®Google Scholar
• Wiltse J, Dellarco V L (1996). US Environmental Protection Agency guidelines for carcinogen risk assessment: Past and future. Mutat Res 365:3–15
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang Z, Mukherjee A B, Linnoila R I (2004). Increased susceptibility of mice lacking Clara cell 10-kDa protein to lung tumorigenesis by 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent carcinogen in cigarette smoke. J Biol Chem 279:29336–29340
   PubMed Web of Science ®Google Scholar
• Zhao C, Vodicka P, Sram RJ, Hemminki K (2000). Human DNA adducts of 1,3- butadiene an important environmental carcinogen. Carcinogenesis 21:107–111
   PubMed Web of Science ®Google Scholar
• Zhou X, Taghizadeh K, Dedon P C (2005). Chemical and biological evidence for base propenals as the major source of the endogenous M1dG adduct in cellular DNA. J Biol Chem 280:25377–25382
   PubMed Web of Science ®Google Scholar